Search by Drug Name or NDC
NDC 23155-0258-31 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is ADENOSINE.
Product Information
| NDC | 23155-0258 |
|---|---|
| Product ID | 23155-258_08c358a9-441f-41ec-bbb1-8a775d47e641 |
| Associated GPIs | 94200005002010 |
| GCN Sequence Number | 031430 |
| GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
| HIC3 | A6V |
| HIC3 Description | CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS |
| GCN | 35352 |
| HICL Sequence Number | 003734 |
| HICL Sequence Number Description | ADENOSINE |
| Brand/Generic | Generic |
| Proprietary Name | Adenosine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Adenosine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | ADENOSINE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202313 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0258-31 (23155025831)
| NDC Package Code | 23155-258-31 |
|---|---|
| Billing NDC | 23155025831 |
| Package | 1 VIAL in 1 CARTON (23155-258-31) / 20 mL in 1 VIAL |
| Marketing Start Date | 2021-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |